Evidence map›Paper›PMID 27150638›Full record

ArticleScientific reports2016

Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification.

Xunxun Wu, Xiaofei Chen, Jia Dan, Yan Cao, Shouhong Gao, Zhiying Guo, Philipp Zerbe, Yifeng Chai, Yong Diao, Lei Zhang

RetractedErratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Xunxun WuSchool of Biomedical Science, Institute of Molecular Medicine, Huaqiao University, Quanzhou 362021, PR China.
Xiaofei ChenSchool of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200433, PR China.
Jia DanSchool of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200433, PR China.
Yan CaoSchool of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200433, PR China.
Shouhong GaoSchool of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200433, PR China.
Zhiying GuoSchool of Biomedical Science, Institute of Molecular Medicine, Huaqiao University, Quanzhou 362021, PR China.
Philipp ZerbeDepartment of Plant Biology, University of California, Davis, CA 95616, USA.
Yifeng ChaiSchool of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200433, PR China.
Yong DiaoSchool of Biomedical Science, Institute of Molecular Medicine, Huaqiao University, Quanzhou 362021, PR China.
Lei ZhangSchool of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200433, PR China.
Shanghai Changzheng Hospital · CNHuaqiao University · CNSecond Military Medical University · CNUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese Medicine (TCM) has been developed for thousands of years and has formed an integrated theoretical system based on a large amount of clinical practice. However, essential ingredients in TCM herbs have not been fully identified, and their precise mechanisms and targets are not elucidated. In this study, a new strategy combining comprehensive two-dimensional K562/cell membrane chromatographic system and in silico target identification was established to characterize active components from Indigo naturalis, a famous TCM herb that has been widely used for the treatment of leukemia in China, and their targets. Three active components, indirubin, tryptanthrin and isorhamnetin, were successfully characterized and their anti-leukemia effects were validated by cell viability and cell apoptosis assays. Isorhamnetin, with undefined cancer related targets, was selected for in silico target identification. Proto-oncogene tyrosine-protein kinase (Src) was identified as its membrane target and the dissociation constant (Kd) between Src and isorhamnetin was 3.81 μM. Furthermore, anti-leukemia effects of isorhamnetin were mediated by Src through inducing G2/M cell cycle arrest. The results demonstrated that the integrated strategy could efficiently characterize active components in TCM and their targets, which may bring a new light for a better understanding of the complex mechanism of herbal medicines.

Indexed as

Antineoplastic AgentsApoptosisCell MembraneCell SurvivalChinaChromatographyComputational BiologyHumansIndigoferaK562 CellsPlant StructuresProto-Oncogene MasAntineoplastic AgentsMAS1 protein, humanProto-Oncogene Mas

Identifiers

PMID27150638
PMCPMC4858665
OpenAlexW2345903473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.